Wortmannin was found to inhibit B-CLL migration to stromal cells mediated by CXCR4–CXCL12 (Burger et al., 1999) and CXCR5–CXCL13 (Burkle et al., 2007). The gene discussed is CXCL13; the disease is B-cell chronic lymphocytic leukemia.